Neural Therapeutics Inc.
NURL
CNSX
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -81.50K | -73.70K | -152.70K | -90.40K | -130.70K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -5.30K | 5.80K | 5.70K | 5.50K | 9.10K |
| Change in Net Operating Assets | 81.50K | 67.20K | 130.50K | 50.40K | 127.60K |
| Cash from Operations | -5.20K | -700.00 | -16.50K | -34.40K | 5.90K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 300.00 | -- | 11.00K | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 461.40K | -- | 55.00K | 0.00 | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -95.20K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | 0.00 | 0.00 |
| Cash from Financing | 324.90K | -- | 48.20K | 0.00 | -70.50K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 319.70K | -700.00 | 31.60K | -34.40K | -64.60K |